Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements Of Cash Flows

v3.21.2
Condensed Consolidated Statements Of Cash Flows - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Cash flows from operating activities:    
Net earnings (loss) $ 474 $ 225
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation and amortization 257 286
Stock-based compensation 35 27
Share of (earnings) losses of affiliates, net 54 64
Realized and unrealized (gains) losses on financial instruments, net (60) 115
Deferred income tax expense (benefit) (10) 1
Other, net 7 4
Changes in operating assets and liabilities    
Decrease (increase) in accounts receivable 429 531
Decrease (increase) in inventory (133) 108
Decrease (increase) in prepaid expenses and other assets 64 37
(Decrease) increase in trade accounts payable (136) (152)
(Decrease) increase in accrued and other liabilities (279) (48)
Net cash provided (used) by operating activities 702 1,198
Cash flows from investing activities:    
Investment in and loans to cost and equity investees (139) (55)
Capital expenditures (110) (108)
Expenditures for television distribution rights (170) (10)
Cash proceeds from dispositions of investments 2  
Proceeds from sale of fixed assets 40  
Other investing activities, net (2) 7
Net cash provided (used) by investing activities (379) (166)
Cash flows from financing activities:    
Borrowings of debt 302 753
Repayments of debt (230) (1,477)
Repurchases of Qurate Retail common stock (105)  
Withholding taxes on net share settlements of stock-based compensation (24) (2)
Derivative payments to counterparties (81)  
Derivative proceeds from counterparties 24  
Dividends paid to noncontrolling interest (31) (30)
Dividends paid to common shareholders (13)  
Other financing activities, net (6) 2
Net cash provided (used) by financing activities (164) (754)
Effect of foreign currency exchange rates on cash, cash equivalents and restricted cash (15) (3)
Net increase (decrease) in cash, cash equivalents and restricted cash 144 275
Cash, cash equivalents and restricted cash at beginning of period 814 681
Cash, cash equivalents and restricted cash at end of period $ 958 $ 956